We had fully expected that both of these marker genes would present a hypermethylation phenotype in the chronically CSE-treated urothelial cells as RUNX3 hypermethylation in bladder cancer is associated with smoking [7] and PRSS8 hypermethylation correlates with bladder cancer progression [9]. This evidence concerns the gene PRSS8 and urinary bladder cancer.